��������

Anna Raba is a Scientist with a background in Translational Medicine and Tumor Biology. Anna has worked in various research positions in companies such as CRELUX, Boehringer Ingelheim, and Merck KGaA, as well as completing internships at institutions like Stockholm University and Ontario Cancer Institute. Anna's expertise lies in targeting nucleotide metabolism to improve anti-cancer therapy.